Jubilant Launched Remdesivir in India for COVID-19 Treatment

JUBI-R by Jubliant Life Sciences in Indian market is available at a price of Rs 4,700 and available to over 1,000 hospitals will be used for COVID-19.

author-image
SMEStreet Desk
New Update
shyam bhartia, Jubliant Life Sciences, COVID-19
COVID 19 Jubliant Life Sciences shyam bhartia